Tonmya: the newest FDA-approved fibromyalgia medicine

Tonmya is a prescription sublingual tablet containing cyclobenzaprine hydrochloride. “Sublingual” means it dissolves under the tongue rather than being swallowed like a conventional tablet. It is taken at bedtime according to its prescribing instructions and is approved for adults with fibromyalgia.

The approval was supported by randomized, placebo-controlled Phase 3 studies that evaluated pain over 14 weeks. The treatment groups had statistically greater average reductions in daily pain than placebo. That is meaningful evidence, but it does not mean every person experienced major relief or that the medicine cures fibromyalgia.

How it fits into care

Tonmya expands the prescription options available for adults, particularly when pain and unrefreshing sleep are treatment priorities. A clinician may still recommend another medication first based on prior response, insurance coverage, contraindications, side effects and the symptoms that matter most to you.

It is not known whether Tonmya is safe and effective in children. It is also not a universal first choice for older adults or people with certain medical conditions; the official label contains specific dosage, contraindication, interaction and monitoring information.

Tonmya safety information readers should know

Common adverse reactions reported in the label include mouth numbness, oral discomfort, abnormal taste, drowsiness, tingling or pain in the mouth, fatigue, dry mouth and canker sores. Because it can cause drowsiness, patients need individualized guidance about driving, alcohol and other sedating medicines.

The medicine has important contraindications and drug-interaction concerns. For example, the label warns about monoamine oxidase inhibitors and the risk of serotonin syndrome with certain serotonergic medicines. It also includes warnings relevant to heart rhythm or conduction problems, recent heart attack, hyperthyroidism, glaucoma, urinary retention and liver impairment. This summary is not a substitute for the full label.

Questions before considering it

• Does it fit my most disruptive symptoms?
• Could it interact with my antidepressant, pain medicine, sleep aid or other prescriptions?
• Do my heart, liver, eye or urinary conditions change the risk?
• What side effects should I report, and when?
• What improvement would count as success, and when will we reassess?
• Is it covered by my insurance, and are prior authorization or alternatives required?

Established medication options are still relevant

Tonmya joins three longer-standing FDA-approved medicines for fibromyalgia in adults: pregabalin, duloxetine and milnacipran. Clinicians also sometimes use other medicines off-label when appropriate. No medicine works for everyone, and benefits may be modest. Selection should match symptoms, other diagnoses, interactions and tolerability.

This table is not a ranking and does not list every risk. For a practical care-team discussion, see our guide to the best doctor to see for fibromyalgia.

The latest prescription does not replace whole-person care

The National Institute of Arthritis and Musculoskeletal and Skin Diseases describes fibromyalgia treatment as a team approach that may include medication, exercise or movement therapy, psychological or behavioral therapy and education. These strategies are not “less real” than medicine.

Complementary approaches may help some symptoms, but evidence and safety vary. Our guides to acupressure for fibromyalgia and mistakes to avoid with fibromyalgia explain how to approach these choices more safely.

What fibromyalgia treatments are still being researched?

Research continues in medication repurposing, neuromodulation, noninvasive brain or nerve stimulation, TENS, behavioral interventions, sleep-focused care and personalized treatment prediction. A study listed on ClinicalTrials.gov does not mean a treatment is proven, FDA approved or available outside research.

Trial statuses can change. Use ClinicalTrials.gov’s fibromyalgia search to check current eligibility and locations. Review any study with your regular healthcare professional and ask about randomization, placebo, travel, costs, compensation, possible harms and what happens after the trial.

How to discuss the latest treatments with your doctor

1. Bring an updated list of prescriptions, over-the-counter products and supplements.
2. Name the two symptoms that most limit your life.
3. Describe what you have already tried, for how long and why you stopped.
4. Ask whether Tonmya or another option fits your medical history.
5. Agree on a measurable goal and follow-up date.
6. Ask what not to combine and what symptoms need prompt help.

If navigating treatment feels overwhelming, our article on finding support for fibromyalgia includes appointment and communication strategies.